Overview / Abstract: |
Earn 1.0 hour (0.1 CEUs) of continuing education credit when you purchase the webinar, MEN AND COVID SEVERITY " New Research that Links Them … What Are the Implications? This activity will help pharmacists and pharmacy technicians understand why men experienced more severe outcomes from COVID-19 compared to women, and how this knowledge may apply to other acute viral illnesses. Participants will also explore the current evidence on testosterone's role in cardiovascular disease and prostate cancer, gaining the tools to discuss its risks and benefits confidently. By the end of the activity, pharmacists and technicians will be better prepared to educate both patients and healthcare providers on testosterone-related health concerns. |
Expiration |
Nov 02, 2025 |
Discipline(s) |
Pharmacy CPE |
Format |
Online, Webinar / Webcast / Video |
Cost |
Member Price: $20 | Non-Member Price: $35 |
Credits / Hours |
1 hour (0.1 CEUs) |
Accreditation |
The American College of Apothecaries, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. All sessions carrying the ACPE program number are approved for continuing education credit. |
Presenters / Authors / Faculty |
Bruce Biundo |
Keywords / Search Terms |
American College of Apothecaries, Pharmacists, Pharmacy Technicians, CE, testosterone and COVID-19, men’s health, hormone therapy, cardiovascular risk, prostate cancer, DHT, estradiol, immune response, cytokine storm, TRAVERSE study, viral illness, hormone research, continuing education, webinar |